An international company, with headquarter based in Parma, Italy. In short: four international research centres, three production facilities, 1 300 active patents, 42 ongoing projects in various phases of clinical development, and medicines available in more than 89 countries. The Swedish office is based in Stockholm.
Chiesi Pharma
Strong focus on research, development, production and the commercialisation of innovative medicines in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas.
